COMMUNIQUÉS West-GlobeNewswire

AxoGen, Inc. to Present at the Morgan Stanley Global Healthcare Conference
28/08/2018
ALACHUA, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced that Peter J. Mariani, chief [...]
Aleafia Posts Record Revenue in Q2 with 160,000 sq ft Niagara Greenhouse to be Fully Operational in Late 2018
28/08/2018
Annual growing capacity to reach 38,000 kg in early 2019 TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- The Board of Directors of Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF) (“ Aleafia “) or (the “ Company “), one of [...]
XOMA to Present at the H. C. Wainwright 20th Annual Global Investment Conference
28/08/2018
EMERYVILLE, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, announced today its Chief Executive Officer, Jim [...]
First Patient Enrolled in Anavex Life Sciences Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease
28/08/2018
ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints measuring Safety, and Cognitive and Functional Efficacy (ADAS [...]
PetVivo Holdings, Inc. Adds Daniel P. Collins, Ph.D. as Chief Science Officer
28/08/2018
MINNEAPOLIS, Aug. 28, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCPINK:PETV), an emerging biomedical device company, is pleased to announce the addition of Daniel P. Collins, Ph.D., as Chief Science Officer (CSO [...]
Axsome Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018
NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Agios to Present at the Citi 13th Annual Biotech Conference Wednesday, September 5, 2018
28/08/2018
CAMBRIDGE, Mass, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is [...]
EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
28/08/2018
WATERTOWN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer
28/08/2018
SAN DIEGO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that it has appointed Andrew Sassine as Interim Chief Financial Officer (CFO), [...]
Emerald Health Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
28/08/2018
VICTORIA, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that Chris Wagner, Chief Executive Officer, will present a corporate [...]
Revive Therapeutics Provides Corporate Update
28/08/2018
TORONTO, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”) , a specialty cannabis company focused on the research, development and [...]
Radient Technologies Inc. Reports First Quarter 2019 Financial Results and Provides Corporate Update
28/08/2018
EDMONTON, Alberta, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) is pleased to announce financial results for the first fiscal quarter ended June 30, 2018 [...]
Dynavax Announces Publication of Two Papers in Leading Oncology Journal Highlighting Data From Clinical Studies of Its TLR9 Agonist, SD-101
28/08/2018
Cancer Discovery Features Reports of Early Clinical Trials of SD-101 in Lymphoma and Advanced Melanoma BERKELEY, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced [...]
Bhang Accelerates Growth with New Headquarters in Miami
28/08/2018
Recent Real Estate Deal Enables Bhang Corporation to Significantly Expand Operations MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Bhang Corporation , the award-winning company famous for its Bhang-branded cannabis edibles, [...]
G1 Therapeutics to Present at H.C. Wainwright Investment Conference on September 5, 2018
28/08/2018
RESEARCH TRIANGLE PARK, N.C., Aug. 28, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Buck Phillips, Chief Financial Officer and Senior Vice [...]
Financial Calendar 2018/19
28/08/2018
Company Announcement No. 13/2018 Attachment No 13 2018_Financial Calendar 20182019
Transactions in relation to share buyback program
28/08/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Aino Health AB (publ): Aino Health signs agreement with Sjuksyrra AB
28/08/2018
28 August 2018 Because of increased demand for Aino Health's offering and to continue increasing scalability, Aino Health has signed an agreement with Sjuksyrra AB. Sjuksyrra AB is a staffing company in health care [...]
GENFIT: Major Milestone achieved with full recruitment of the Phase 2 trial evaluating elafibranor in PBC
28/08/2018
GENFIT: Major Milestone achieved with full recruitment of the Phase 2 trial evaluating elafibranor in PBC Final patient randomized in a Phase 2a clinical trial evaluating efficacy and safety of elafibranor in PBC ( [...]

Pages